Market Tracker

08/27 10:52am ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

70.80
Real-Time Quote
 -0.75 / -1.05%
Today’s Change
55.04
Today|||52-Week Range
84.25
+0.64%
Year-to-Date

Today’s Trading

Previous close71.55
Today’s open71.28
Day’s range70.01 - 71.50
Volume281,308
Average volume (3 months)1,159,492
Market cap$10.5B
Dividend yield--
Data as of 10:37am ET, 08/27/2014

Growth & Valuation

Earnings growth (last year)-34.74%
Earnings growth (this year)+4.51%
Earnings growth (next 5 years)+12.50%
Revenue growth (last year)+10.82%
P/E ratioNM
Price/Sales17.67
Price/Book7.65

Competitors

 Today’s
change
Today’s
% change
SLXPSalix Pharmaceutical...+0.35+0.22%
ENDPEndo International P...-0.15-0.23%
JAZZJazz Pharmaceuticals...+1.02+0.62%
INCYIncyte Corp-0.07-0.13%
Data as of 10:52am ET, 08/27/2014

Financials

Next reporting dateOctober 23, 2014
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$548.4M
Annual profit (last year)-$176.4M
Net profit margin-32.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts